JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 108:900-903
© 2009 International Anesthesia Research Society
doi: 10.1213/ane.0b013e31819240a5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Capacchione, J. F.
Right arrow Articles by Muldoon, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capacchione, J. F.
Right arrow Articles by Muldoon, S. M.
Related Collections
Right arrow Mechanisms
Right arrow Complications
Right arrow Patient Safety
Right arrow Genetics
Right arrow Pharmacology


PATIENT SAFETY

Trauma, Systemic Inflammatory Response Syndrome, Dietary Supplements, Illicit Steroid Use and a Questionable Malignant Hyperthermia Reaction

John F. Capacchione, MD, Matthew C. Radimer, MD, Jeffrey S. Sagel, DO, Gregory P. Kraus, MD, Nyamkhishig Sambuughin, PhD, and Sheila M. Muldoon, MD

From the Departments of Anesthesiology, Uniformed Services University of the Health Sciences, Walter Reed Army Medical Center, National Naval Medical Center, Bethesda, Maryland.

Address correspondence and reprint requests to John F. Capacchione, MD, Uniformed Services University of the Health Sciences, Department of Anesthesiology, 4301 Jones Bridge Rd., Bethesda, MD 20814. Address e-mail to jcapacchione{at}usuhs.mil.

Abstract

BACKGROUND: Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle calcium regulation associated primarily, but not exclusively, with mutations in the skeletal muscle ryanodine receptor. Associated environmental factors, however, may also be important for expression of the syndrome.

METHODS AND RESULTS: A 24-yr-old trauma patient developed a fulminant MH crisis after a 3 minute exposure to sevoflurane. A thorough evaluation of underlying co-morbidities revealed a number of environmental factors that could have altered skeletal muscle calcium regulation, and may have potentially influenced the effects of volatile inhaled anesthetics. Since MH is a syndrome characterized by abnormal skeletal muscle calcium regulation, other factors that alter calcium homeostasis may exacerbate the impact of inhaled MH-triggering drugs.

CONCLUSIONS: While a thorough history of MH episodes in a proband and family is emphasized as part of a complete preanesthetic evaluation, obtaining a history of other environmental entities that may alter calcium regulation may be equally important to knowing the family history.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. Parness
You're "Hot" from Pumping Iron?
Anesth. Analg., March 1, 2009; 108(3): 711 - 713.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.